Gland Pharma Limited Gland Pharma Limited

Gland Pharma Limited

GLAND

주식 순위 #3298
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
주가
$32.32
시가총액
$5.33B
변동 (1일)
-3.01%
변동 (1년)
47.99%
국가
IN
거래 Gland Pharma Limited (GLAND)

카테고리

Healthcare
Gland Pharma Limited (GLAND)의 P/S 비율
October 2026 기준 P/S 비율 TTM: 7.47
Gland Pharma Limited의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 7.47입니다. 2024년 말 기준 P/S 비율은 5.27였습니다.
Gland Pharma Limited의 P/S 비율 기록 (2017 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
2026 (TTM) 7.47 63.72%
2025 4.56 -13.61%
2024 5.27 -9.26%
2023 5.81 -52.56%
2022 12.25 7.08%
2021 11.44 4.38%
2020 10.96 -26.45%
2019 14.91 -20.73%
2018 18.80 -1.35%
2017 19.06 0.00%
유사 기업 또는 경쟁사의 P/S 비율